Atriva Therapeutics

Atriva Therapeutics

Atriva Therapeutics

Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.
Founded
2015
Raised
$8.6M
Follow us
Alexa global traffic share
Latest funding Show all
$8,600,000
Debt financing - 2020
High-Tech Gründerfonds Meneldor
Undisclosed amount
Venture capital (Series A) - 2019
High-Tech Gründerfonds (HTGF) Meneldor
Team Size
1–10
Employees
Location
Headquarters
$8,600,000 Debt financing
FinSMEs

Atriva Therapeutics Closes €8.6M Oversubscribed Convertible Loan

Venture capital (Series A)
FinSMEs

Atriva Therapeutics Raises Initial Series A Funding

Seed fund
atriva-therapeutics , High-Tech Gründerfonds

Atriva Therapeutics GmbH - Atriva receives seed financing to develop its next generation influenza therapeutic